Predictors of risks from obesity that impact poor prognosis in patients infected with Sars-CoV-2

Authors

DOI:

https://doi.org/10.33448/rsd-v9i9.7961

Keywords:

Obesity; COVID-19; Risk factors.

Abstract

Coronavirus 2019 is considered a morbidity transmitted by the positive-chain RNA SARS-CoV-2 virus, which causes deleterious effects to the respiratory system and can trigger from mild to fatal symptoms. Parallel to the current pandemic crisis is obesity, another pandemic, characterized as an accumulation of dysfunctional adipose tissue that is generally correlated with low inflammation systemic status. Thus, the objective of the study was to carry out an integrative literature review in order to investigate the risk factors related to obesity that reverberate for the poor prognosis of obese patients infected with Sars-Cov-2. The methodology was based on the analysis of articles taken from PUBMED, in the English language that dealt with the theme, whose search was made using the descriptors: obesity, covid-19 and risk factors to identify articles published in 2020. The Recent findings elucidate a negative association in obese individuals admitted with SARS-CoV-2, especially with regard to the immune response, a marked risk for the development of ARDS, since both share common metabolic and inflammatory pathways, which reverberate to exacerbation of the disease. Thus, in order to avoid progression and reduce the serious results of COVID-19, it is necessary to monitor and manage more ephemerally and judiciously this public by health professionals, in addition, it is pertinent to adopt measures based on healthy lifestyle to improve both nutritional status, as well as systemic markers of immune functions in this pandemic period.

Author Biography

Priscylla Tavares Almeida, Faculdade de Juazeiro do Norte

Nutricionista especialista em nutrição e treinamento físico pela Faculdade de Juazeiro do Norte

References

Abbas, A. M., Fathy, S. K., Fawzy, A. T., Salem, A. S., & Shawky, M. S. (2020). Os efeitos mútuos de COVID-19 e obesidade. Remédio para obesidade , 19 , 100250. https://doi.org/10.1016/j.obmed.2020.100250

Alberca, R. W., Oliveira, L. D. M., Branco, A. C. C. C., Pereira, N. Z., & Sato, M. N. (2020). Obesity as a risk factor for COVID-19: an overview. Critical Reviews in Food Science and Nutrition, 1-15. . doi:10.1080/10408398.2020.1775546

Cai, S. H., Liao, W., Chen, S. W., Liu, L. L., Liu, S. Y., & Zheng, Z. D. (2020). Association between obesity and clinical prognosis in patients infected with SARS-CoV-2. Infectious diseases of poverty, 9(1), 80. https://doi.org/10.1186/s40249-020-00703-5

Chait, A., den Hartigh, L. J. Adipose Tissue Distribution, Inflammation and Its Metabolic Consequences, Including Diabetes and Cardiovascular Disease. Front Cardiovasc Med.

, 22. Published 2020 Feb 25. doi:10.3389/fcvm.2020.00022

Cummings, M. J., Baldwin, M. R., Abrams, D., Jacobson, S. D., Meyer, B. J., Balough, E. M., & Hochman, B. R. (2020). Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study. The Lancet. https://doi.org/10.1016/S0140-6736(20)31189-2

Deng, M., Qi, Y., Deng, L., Wang, H., Xu, Y., Li, Z., Meng, Z., Tang, J., & Dai, Z. (2020). Obesity as a Potential Predictor of Disease Severity in Young COVID-19 Patients: A Retrospective Study. Obesity (Silver Spring, Md.), 10.1002/oby.22943. Advance online publication. https://doi.org/10.1002/oby.22943

Giacomelli, A., Ridolfo, AL, Milazzo, L., Oreni, L., Bernacchia, D., Siano, M., Bonazzetti, C., Covizzi, A., Schiuma, M., Passerini, M., Piscaglia , M., Coen, M., Gubertini, G., Rizzardini, G., Cogliati, C., Brambilla, AM, Colombo, R., Castelli, A., Rech, R., Riva, A., Galli, M. (2020). Mortalidade em 30 dias em pacientes hospitalizados com COVID-19 durante a primeira onda da epidemia italiana: Um estudo de coorte prospectivo. Pesquisa farmacológica , 158 , 104931. https://doi.org/10.1016/j.phrs.2020.104931

Hamer, M., Kivimäki, M., Gale, C. R., & Batty, G. D. (2020). Lifestyle risk factors, inflammatory mechanisms, and COVID-19 hospitalization: A community-based cohort study of 387,109 adults in UK. Brain, behavior, and immunity, 87, 184–187. https://doi.org/10.1016/j.bbi.2020.05.059

Hernández-Garduño E. (2020). Obesity is the comorbidity more strongly associated for Covid-19 in Mexico. A case-control study. Obesity research & clinical practice, 14(4), 375–379. https://doi.org/10.1016/j.orcp.2020.06.001

Hur, K., Price, C., Gray, E. L., Gulati, R. K., Maksimoski, M., Racette, S. D., Schneider, A. L., & Khanwalkar, A. R. (2020). Factors Associated With Intubation and Prolonged Intubation in Hospitalized Patients With COVID-19. Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery, 163(1), 170–178. https://doi.org/10.1177/0194599820929640

Klang E, Kassim G, Soffer S, Freeman R, Levin MA, Reich DL. Morbid Obesity as an Independent Risk Factor for COVID-19 Mortality in Hospitalized Patients Younger than 50 [published online ahead of print, 2020 May 23]. Obesity (Silver Spring). 2020;10.1002/oby.22913. doi:10.1002/oby.22913

Korakas, E., Ikonomidis, I., Kousathana, F., Balampanis, K., Kountouri, A., Raptis, A., & Lambadiari, V. (2020). Obesity and COVID-19: Immune and metabolic derangement as a possible link to adverse clinical outcomes. https://doi.org/10.1152/ajpendo.00198.2020

Michalakis, K., & Ilias, I. (2020). SARS-CoV-2 infection and obesity: Common inflammatory and metabolic aspects. Diabetes & metabolic syndrome, 14(4), 469–471. https://doi.org/10.1016/j.dsx.2020.04.033

Muscogiuri, G., Pugliese, G., Barrea, L., Savastano, S., & Colao, A. (2020). Commentary: Obesity: The "Achilles heel" for COVID-19?. Metabolism: clinical and experimental, 108, 154251. https://doi.org/10.1016/j.metabol.2020.154251

Palaiodimos, L., Kokkinidis, D. G., Li, W., Karamanis, D., Ognibene, J., Arora, S., Southern, W. N., & Mantzoros, C. S. (2020). Severe obesity, increasing age and male sex are independently associated with worse in-hospital outcomes, and higher in-hospital mortality, in a cohort of patients with COVID-19 in the Bronx, New York. Metabolism: clinical and experimental, 108, 154262. https://doi.org/10.1016/j.metabol.2020.154262

Petersen, A., Bressem, K., Albrecht, J., Thieß, H. M., Vahldiek, J., Hamm, B., Makowski, M. R., Niehues, A., Niehues, S. M., & Adams, L. C. (2020). The role of visceral adiposity in the severity of COVID-19: Highlights from a unicenter cross-sectional pilot study in Germany. Metabolism: clinical and experimental, 110, 154317. https://doi.org/10.1016/j.metabol.2020.154317

Qingxian, C., Chen, F., Fang, L., Xiaohui, L., Tao, W., Qikai, W. Q., Zhaoqin, W., Liu, Y., a Jun, C., Lei, L., Lin, X., Obesity and COVID-19 Severity in a Designated Hospital in Shenzhen, China (3/13/2020). https://doi.org/.2139/ssrn.

Rychter, A. M., Zawada, A., Ratajczak, A. E., Dobrowolska, A., & Krela-Kaźmierczak, I. (2020). Should patients with obesity be more afraid of COVID-19?. Obesity reviews: an official journal of the International Association for the Study of Obesity, 21(9), e13083. https://doi.org/10.1111/obr.13083

Sattar, N., McInnes, I. B., & McMurray, J. (2020). Obesity Is a Risk Factor for Severe COVID-19 Infection: Multiple Potential Mechanisms. Circulation, 142(1), 4–6. https://doi.org/10.1161/CIRCULATIONAHA.120.047659

Sousa, L. M. M. S., Marques, V. C. M. A., & Severino, S. S. (2017). Metodologia de revisão integrativa da literatura em enfermagem. Revista Investigação Enfermagem, Ser. II (21), 17-26.

Simonnet, A., Chetboun, M., Poissy, J., Raverdy, V., Noulette, J., Duhamel, A., Labreuche, J., Mathieu, D., Pattou, F., Jourdain, M., & LICORN and the Lille COVID-19 and Obesity study group (2020). High Prevalence of Obesity in Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) Requiring Invasive Mechanical Ventilation. Obesity (Silver Spring, Md.), 28(7), 1195–1199. https://doi.org/10.1002/oby.22831

Yang, Y., Ding, L., Zou, X., Shen, Y., Hu, D., Hu, X., Li, Z., & Kamel, I. R. (2020). Visceral Adiposity and High Intramuscular Fat Deposition Independently Predict Critical Illness in Patients with Sars-COV-2. Obesity (Silver Spring, Md.), 10.1002/oby.22971. Advance online publication. https://doi.org/10.1002/oby.22971

Zabetakis, I., Lordan, R., Norton, C., & Tsoupras, A. (2020). COVID-19: The Inflammation Link and the Role of Nutrition in Potential Mitigation. Nutrients, 12(5), 1466. https://doi.org/10.3390/nu12051466

Downloads

Published

13/09/2020

How to Cite

ALMEIDA, P. T.; TEIXEIRA, Y. .; LOPES, L. S. .; SOBREIRA, T. X. .; SANTANA, E. N. da C. .; SILVA, C. J. R. S. da; ALMEIDA, A. de; BRASIL, M. Y. O. .; ALMEIDA, A. de .; CARRARO, T. C. M. M. .; MORAES, P. S. M. .; SILVA, R. F. da .; OLIVEIRA, R. P. de .; TRAJANO, J. A.; ARAÚJO, B. da C. .; ARAÚJO, P. J. M. de .; PIRES, I. G. .; RUSSELL, E. S. .; FIGUEIREDO, A. K. G. de .; SOUZA, E. D. S. de .; SILVA, P. N. da .; LIRA, B. G. de .; BISPO, R. S. Predictors of risks from obesity that impact poor prognosis in patients infected with Sars-CoV-2. Research, Society and Development, [S. l.], v. 9, n. 9, p. e929997961, 2020. DOI: 10.33448/rsd-v9i9.7961. Disponível em: https://rsdjournal.org/index.php/rsd/article/view/7961. Acesso em: 22 nov. 2024.

Issue

Vol. 9 No. 9

Section

Review Article

License

Copyright (c) 2020 Priscylla Tavares Almeida; Ygor Teixeira; Letícia Souza Lopes; Taís Ximenes Sobreira; Esaú Nicodemos da Cruz Santana; Cicero Jordan Rodrigues Sobreira da Silva; Amanda de Almeida; Maria Yngrid Oliveira Brasil; Alanny de Almeida; Talita Cristina Moreira Moraes Carraro; Pamela Suely Moreira Moraes; Rejane Ferreira da Silva; Raquel Peres de Oliveira; Janice Alves Trajano; Brunna da Cruz Araújo; Paula Joseany Miranda de Araújo; Isadora Garcia Pires; Emanuelle Silva Russell; Ana Karine Gomes de Figueiredo; Ellen Diana Silva de Souza; Paulina Nunes da Silva; Beatriz Gonçalves de Lira; Rosângela Silva Bispo

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Authors who publish with this journal agree to the following terms:

1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.

2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.

3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.